Real-time enrollment status for this hemophilia b clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT06379789 |
| Recruiting Status | Recruiting |
| Condition | Hemophilia B |
| Phase | Clinical Trial |
| Target Enrollment | 130 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | February 4, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT06379789 is currently recruiting participants. This clinical trial study for hemophilia b is actively seeking new participants at 9 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06379789 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06379789 was last updated 3 weeks ago (February 4, 2026). HelloStudys verifies this status automatically.